{
  "ticker": "LH",
  "last_updated": "2025-04-15T12:45:33.214155",
  "retention_years": 3,
  "count": 17,
  "transactions": [
    {
      "id": 28662,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-08",
      "transaction_shares": "1116",
      "transaction_price": "232.67",
      "transaction_type": "S",
      "shares_after_transaction": "6687.4022"
    },
    {
      "id": 28660,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "16291.78"
    },
    {
      "id": 28661,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schroeder Mark S",
      "reporting_owner_cik": "0001793112",
      "reporting_owner_position": "EVP, President-Diagnostics Lab",
      "transaction_date": "2022-11-05",
      "transaction_shares": "2010",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "8697.4022"
    },
    {
      "id": 28656,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Schechter Adam H",
      "reporting_owner_cik": "0001376841",
      "reporting_owner_position": "President & CEO",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "18481"
    },
    {
      "id": 28659,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-11-01",
      "transaction_shares": "12032",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "39190"
    },
    {
      "id": 28667,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Kirchgraber Paul R",
      "reporting_owner_cik": "0001791393",
      "reporting_owner_position": "CEO, Covance Drug Development",
      "transaction_date": "2022-11-01",
      "transaction_shares": "2007",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "13922"
    },
    {
      "id": 12585,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 28663,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 12587,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 28665,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 12589,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 28668,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 12588,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    },
    {
      "id": 28666,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    },
    {
      "id": 2651,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-06-07",
      "transaction_shares": "42.006",
      "transaction_price": "242.193",
      "transaction_type": "P",
      "shares_after_transaction": "14171.9166"
    },
    {
      "id": 12586,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-06-07",
      "transaction_shares": "42.006",
      "transaction_price": "242.193",
      "transaction_type": "P",
      "shares_after_transaction": "14171.9166"
    },
    {
      "id": 28664,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-06-07",
      "transaction_shares": "42.006",
      "transaction_price": "242.193",
      "transaction_type": "P",
      "shares_after_transaction": "14171.9166"
    }
  ]
}